CVE-2010-2657

Description

Opera before 10.60 on Windows and Mac OS X does not properly prevent certain double-click operations from running a program located on a web site, which allows user-assisted remote attackers to execute arbitrary code via a crafted web page that bypasses a dialog.

Category

9.3
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 0.66% Top 30%
Vendor Advisory opera.com Vendor Advisory opera.com Vendor Advisory opera.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://secunia.com/advisories/40375 third party advisory
http://www.opera.com/docs/changelogs/mac/1060/ vendor advisory
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A11856 vdb entry third party advisory signature
http://www.opera.com/support/search/view/957/ vendor advisory
http://www.vupen.com/english/advisories/2010/1664 permissions required vdb entry third party advisory
http://www.opera.com/docs/changelogs/windows/1060/ vendor advisory

Frequently Asked Questions

What is the severity of CVE-2010-2657?
CVE-2010-2657 has been scored as a critical severity vulnerability.
How to fix CVE-2010-2657?
To fix CVE-2010-2657, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-2657 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2010-2657 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.